0001437749-24-020547.txt : 20240617 0001437749-24-020547.hdr.sgml : 20240617 20240617180820 ACCESSION NUMBER: 0001437749-24-020547 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240613 FILED AS OF DATE: 20240617 DATE AS OF CHANGE: 20240617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Cittadine Andrew CENTRAL INDEX KEY: 0001863624 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39070 FILM NUMBER: 241049601 MAIL ADDRESS: STREET 1: C/O 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Monopar Therapeutics CENTRAL INDEX KEY: 0001645469 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 320463781 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 BUSINESS PHONE: 8473880349 MAIL ADDRESS: STREET 1: 1000 SKOKIE BLVD SUITE 350 CITY: WILMETTE STATE: IL ZIP: 60091 4 1 rdgdoc.xml FORM 4 X0508 4 2024-06-13 0001645469 Monopar Therapeutics MNPR 0001863624 Cittadine Andrew 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 1 Chief Operating Officer 0 Common Stock 2024-06-13 4 P 0 12000 0.91 A 129624 D Common Stock 2024-06-14 4 P 0 12000 0.9313 A 141624 D Common Stock 2024-06-17 4 P 0 12000 0.89990 A 153624 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.9100 to $0.93994, inclusive. The reporting person undertakes to provide to Monopar Therapeutics, any security holder of Monopar Therapeutics, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the preceding sentence. /s/ Kim R Tsuchimoto, Attorney-in-fact 2024-06-17